In contrast to neurodegerative conditions and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has actually been fairly very well founded. The deamidation of unique glutamine residues qualified by TG2 in gluten peptides has long been revealed to reinforce peptide binding for the